Fremanezumab

Trade Name: 
Ajovy
Manufacturer/Distributor: 
Teva Canada Ltd.
Classification: 
Anti-calcitonin gene-related peptide
ATC Class: 
N02CD03 - fremanezumab
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2020/04/09
Date Marketed in Canada (yyyy/mm/dd): 
2020/08/04
Presentation: 
S/C injection: 225 mg/1.5 mL. DIN: 02497859
Comments: 
For prevention of migraine in adults who have at least four migraine days per month.